[go: up one dir, main page]

NO20075199L - Treatment or prevention of pruritus - Google Patents

Treatment or prevention of pruritus

Info

Publication number
NO20075199L
NO20075199L NO20075199A NO20075199A NO20075199L NO 20075199 L NO20075199 L NO 20075199L NO 20075199 A NO20075199 A NO 20075199A NO 20075199 A NO20075199 A NO 20075199A NO 20075199 L NO20075199 L NO 20075199L
Authority
NO
Norway
Prior art keywords
pruritus
treatment
prevention
oxaprozin
medicaments
Prior art date
Application number
NO20075199A
Other languages
English (en)
Inventor
Morten Sloth Weidner
Original Assignee
Astion Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astion Pharma As filed Critical Astion Pharma As
Publication of NO20075199L publication Critical patent/NO20075199L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Oppfinnelsen tilveiebringer fremgangsmåter og medikamenter for behandling av pruritus generelt, eller pruritus forårsaket av eller forbundet med dermatologiske sykdommer, herunder behandling av den underliggende sykdommen ved topisk administrasjon på huden eller ved systemisk administrasjon av Oxaprozin eller en nært beslektet forbindelse eller salt derav til et individ.
NO20075199A 2005-03-30 2007-10-11 Treatment or prevention of pruritus NO20075199L (no)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DKPA200500438 2005-03-30
DKPA200500437 2005-03-30
US69477405P 2005-06-27 2005-06-27
DKPA200500949 2005-06-27
DKPA200500948 2005-06-27
US69504005P 2005-06-28 2005-06-28
PCT/DK2006/000180 WO2006102899A2 (en) 2005-03-30 2006-03-30 Oxaprozin or closely related compound for the treatment and prevention of

Publications (1)

Publication Number Publication Date
NO20075199L true NO20075199L (no) 2008-01-02

Family

ID=36215671

Family Applications (3)

Application Number Title Priority Date Filing Date
NO20075199A NO20075199L (no) 2005-03-30 2007-10-11 Treatment or prevention of pruritus
NO20075227A NO20075227L (no) 2005-03-30 2007-10-12 Treatment of eczemas
NO20075218A NO20075218L (no) 2005-03-30 2007-10-12 Dermatological compositions and salts for the treatment of dermatological diseases

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO20075227A NO20075227L (no) 2005-03-30 2007-10-12 Treatment of eczemas
NO20075218A NO20075218L (no) 2005-03-30 2007-10-12 Dermatological compositions and salts for the treatment of dermatological diseases

Country Status (12)

Country Link
EP (3) EP1707201A1 (no)
JP (3) JP2008534528A (no)
KR (3) KR20080005525A (no)
AU (3) AU2006228869A1 (no)
BR (3) BRPI0607648A2 (no)
CA (3) CA2603300A1 (no)
EA (3) EA200702027A1 (no)
EC (3) ECSP077846A (no)
IL (3) IL186022A0 (no)
MX (3) MX2007012051A (no)
NO (3) NO20075199L (no)
WO (3) WO2006102900A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0821537D0 (en) * 2008-11-25 2008-12-31 Union Life Sciences Ltd Therapeutic target
WO2017045081A1 (en) * 2015-09-18 2017-03-23 Delivra Inc. Transdermal formulations for delivery of propionic and acetic acid nsaids, and their use in the treatment of nsaid-responsive diseases and conditions
US11406805B2 (en) 2016-08-08 2022-08-09 Avedro, Inc. Systems and methods for cross-linking treatments of an eye
WO2018078624A1 (en) * 2016-10-25 2018-05-03 Ticure Ltd. Fabp4 as a therapeutic target in skin diseases
EP3720411A4 (en) * 2017-12-07 2021-11-24 Dermavant Sciences GmbH TOPICAL Ointment FORMULATIONS BY PDE-4 INHIBITORS AND THEIR USE FOR TREATMENT OF SKIN DISEASES
RU2685436C1 (ru) * 2018-06-22 2019-04-18 ЗАО "ФармФирма "Сотекс" Трансдермальный препарат для лечения и профилактики болезней суставов и мягких тканей
JP7514598B2 (ja) * 2018-12-20 2024-07-11 小林製薬株式会社 皮膚外用組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE32084B1 (en) * 1967-06-07 1973-04-04 Wyeth John & Brother Ltd Thiazole derivatives
US3578671A (en) 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
IE52909B1 (en) * 1981-04-28 1988-04-13 Wyeth John & Brother Ltd Oxazole derivatives
US4659728A (en) * 1985-02-25 1987-04-21 American Home Products Corporation Hydroxy substituted 4,5-diphenyl-2-oxazole propanoic acid
EP0270316A3 (en) * 1986-12-04 1989-12-06 Pfizer Inc. Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne
US5380738A (en) * 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
US6090834A (en) * 1993-05-21 2000-07-18 G.D. Searle & Co. Substituted oxazoles for the treatment of inflammation
HUT74448A (en) 1993-10-20 1996-12-30 Boots Co Plc Process for preparing pharmaceutical compns. contg. ibuprofen and flurbiprofen for use as anti-pruritic agents
JPH07316075A (ja) 1994-05-26 1995-12-05 Pola Chem Ind Inc 皮膚外用剤
GB9606429D0 (en) 1996-03-27 1996-06-05 Boots Co Plc Pharmaceutical compositions
EP0901372B1 (en) * 1996-05-20 2005-07-20 G.D. Searle LLC. Potassium, sodium and tris oxaprozin salt pharmaceutical formulations
US5976566A (en) * 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
WO2005009342A2 (en) 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
US20050232957A1 (en) 2004-04-14 2005-10-20 Katz Kenneth A Compositions and methods for moisturizing skin

Also Published As

Publication number Publication date
EP1707199A1 (en) 2006-10-04
KR20080005526A (ko) 2008-01-14
WO2006102899A3 (en) 2006-12-28
AU2006228869A1 (en) 2006-10-05
EA200702023A1 (ru) 2008-04-28
MX2007012050A (es) 2008-03-11
ECSP077845A (es) 2008-02-20
JP2008534526A (ja) 2008-08-28
AU2006228870A1 (en) 2006-10-05
JP2008534527A (ja) 2008-08-28
WO2006102899A2 (en) 2006-10-05
ECSP077846A (es) 2008-02-20
ECSP077843A (es) 2008-02-20
JP2008534528A (ja) 2008-08-28
NO20075227L (no) 2007-12-09
CA2603297A1 (en) 2006-10-05
NO20075218L (no) 2007-12-27
CA2605121A1 (en) 2006-10-05
WO2006102900A1 (en) 2006-10-05
IL186021A0 (en) 2008-02-09
EP1707201A1 (en) 2006-10-04
EA200702027A1 (ru) 2008-02-28
WO2006102898A2 (en) 2006-10-05
KR20080005525A (ko) 2008-01-14
EA200702026A1 (ru) 2008-04-28
AU2006228871A1 (en) 2006-10-05
BRPI0609653A2 (pt) 2010-04-20
BRPI0607648A2 (pt) 2009-09-22
IL186022A0 (en) 2008-02-09
WO2006102898A3 (en) 2006-12-28
KR20080011280A (ko) 2008-02-01
MX2007012052A (es) 2008-02-22
BRPI0609535A2 (pt) 2010-04-13
IL186020A0 (en) 2008-01-20
MX2007012051A (es) 2008-02-22
EP1707200A1 (en) 2006-10-04
CA2603300A1 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
EA200971053A1 (ru) Способы лечения кожных язв
NO20080745L (no) Nye peptider for anvendelse i behandling av fedme
EA201290078A1 (ru) Гетероциклические соединения для ингибирования pask
NO20075199L (no) Treatment or prevention of pruritus
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
EA200801580A1 (ru) Новые производные пирониндола и способ их получения
NO20082790L (no) Behandling av type 2 diabetes med en kombinasjon av DPIV inhibitor og metformin eller thiazolidindion
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
MX2010004074A (es) Combinacion 059.
CR9949A (es) Inhibidores de proteina activadora de la 5-lipoxigenasa (flap)
MX2009006327A (es) Compuestos heterociclicos y metodos de uso de los mismos.
EA201100621A1 (ru) Лечение диабета у пациентов, у которых наблюдается недостаточный гликемический контроль несмотря на лечение пероральным или непероральным противодиабетическим лекарственным средством
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
EA201490004A1 (ru) Применение bifidobacterium lactis bl-04 для лечения заболеваний дыхательных путей
ATE457729T1 (de) Verwendung von allopurinol zur behandlung von palmarer/plantarer erythrodysästhesie
EA200802223A1 (ru) 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90
WO2009068659A3 (en) Novel disease treatment by predicting drug association
ATE453642T1 (de) Substituierte phenylaminopyrimidine
NO20064186L (no) Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod
NO20076405L (no) Anvendelse av 24-nor-UDCA
ATE543492T1 (de) Behandlung von lungenkrebs
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
DK1732551T3 (da) Perhexilin til behandling af kronisk hjertesvigt
WO2006108679A3 (en) Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use to combat cancer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application